# 1. Financial Performance ## A. Key Figures * **Revenue:** **₹1,867 Cr** (–16% QoQ) * **EBITDA:** **₹215 Cr** (–19% QoQ) * **PAT:** **₹43 Cr** ## B. Revenue & Volume * **Underlying Demand Weakness:** Adjusted for one-offs—including **₹30 Cr inventory loss** and **₹20 Cr volume deferment**—revenue was flat QoQ, signaling demand-side softness despite stable volumes. * **Pricing & Export Pressures:** Decline driven by raw material corrections, inventory adjustments, and deferred export realizations, with **20,000–22,000 units of energy volumes deferred to July**. ## C. EBITDA & Profit * **Margin Headwinds:** EBITDA decline reflects **₹50 Cr total impact** from inventory valuation losses and delayed shipments, alongside demand-driven margin compression in key value chains. * **Profitability Divergence:** Despite double-digit volume growth in energy and ~10% in non-energy segments, profitability fell sharply YoY, underscoring structural margin challenges. * **Lower Financing Costs:** Finance costs declined sequentially due to a structurally softer interest rate environment, expected to persist into FY26. * **Tax Rate Guidance:** Effective tax rate for FY26 expected to be **below mid-single digits**, lower than prior outlook. ## D. Balance Sheet * **Temporary Working Capital Spike:** Increase driven by postponed June shipments (port/plant inventory lock) and **7–10 day receivables delays**, causing short-term debt uptick. * **Net Debt Discipline:** Management reaffirmed guidance to reduce net debt by **₹200–300 Cr in FY26** from peak of **₹3,500 Cr**, with levels expected to remain stable barring working capital fluctuations of **₹100–200 Cr**. ## E. Cash Flow * **FX Reclassification, Not Gain:** **₹16 Cr FX item** was a reclassification of prior currency fluctuations previously embedded in revenue, now disclosed separately due to reporting changes. * **CFO Delay:** Cash flow from operations for 1Q not available at time of call; to be shared separately with analysts. --- # 2. Product & Segment Performance ## A. Key Figures * **DCB Volumes:** **Down YoY and sequentially** (due to US demand weakness) · **60–65% utilization** (below downstream) * **Fluoro Component:** **Single-digit %** of benzene value chain sales * **Product Portfolio Scale:** **35–40 products** producible via Zone-IV and MPP platforms · **15–20 new products** in pipeline ## B. Energy Applications * **Resilient Demand:** Underlying stability maintained despite disruptions, supported by **diversified product portfolio** and **multi-process expertise** across energy, agrochemicals, dyes, and polymers. * **MMA Dynamics:** Volumes flat QoQ despite strong demand; pricing pressure from competition and falling feedstock costs offset by **first-mover advantage** and **large-scale operations** that preserve market share. * **Future Catalysts:** Improving crack spreads and global leadership in **PPS**—with expanding domestic and export adoption—position the segment for recovery and sustained scale. ## C. Non-Energy Applications * **Mixed Performance:** Agrochemical intermediates under price pressure while dyes, pigments, inks, and pharma held steady; **DCB weakness contrasted with strong recovery in other polymer segments**. * **Strategic Flexibility:** Multi-product assets dynamically reconfigured based on **margin optimization and demand pull**, enabling agile response to shifting regional and end-market conditions. * **New Verticals:** Defense and electronics require dedicated technical assets, with separate initiatives advancing to serve these high-barrier, specialized markets. ## D. MMA Business * **Global Leadership:** Maintains **lowest cost position** and market leadership in MMA, with expansion driven by confidence in long-term demand from robust downstream applications. * **Margin Strategy:** Disproportionate profitability decline versus volume reflects **intentional pricing discipline** to defend leadership, creating near-term margin headwinds. * **Healthy Demand Fundamentals:** Current spread levels fueling broad-based global demand, though regional spread variation creates uneven dynamics across geographies. ## E. DCB & NCB Lines * **DCB Challenges:** Export-dependent DCB business hit by **inventory drawdown and auto demand uncertainty in the US**, leading to underutilization despite competitive positioning against European peers. * **NCB Setbacks:** Domestic-focused NCB line impacted by **unit maintenance issues** and **customer-specific operational difficulties**, affecting performance despite near-total domestic market reliance. * **Asset Strategy:** Clear distinction between **dedicated plants** (cost leadership, global share) and **multi-product facilities** (flexible, contribution-maximizing), aligning with integrated value chain goals. --- # 3. Capacity & Production ## A. Key Figures * **Nitrotoluene Capacity:** **45 KTPA** (from 30 KTPA) · **Ethylation Capacity:** **30 KTPA** (from 10 KTPA) · **MMA Capacity:** **260 KTPA** (from 200 KTPA) * **Zone-IV & MPP Phase-I Commissioning:** Expected by **December CY25** (mechanical completion advanced) * **Remaining Zone-IV Blocks Commissioning:** **January–May CY26** (phase-wise rollout) ## B. Zone-IV Expansion * **Strategic Scale-Up:** Capacity expansions now in ramp-up phase, targeting **high-value, advanced chemistries** to enhance margins and long-term growth trajectory. * **Phased Commercialization:** First phase of Zone-IV and MPP to go live in H2 CY25, with full Zone-IV operational by mid-CY26, enabling **gradual volume ramp-up and de-risked scale-out**. * **Fungible Asset Base:** Facility designed for chlorotoluenes and derivatives, with inherent flexibility to pivot across multiple chemistries, supporting **margin-optimized, demand-driven production**. * **Investment Rationale:** Expansion driven by **demand pull and return-focused discipline**, not contract-backed commitments, underscoring confidence in market positioning. ## C. MPP Commissioning * **Flexible Product Rollout:** MPP launching with **4–5 high-priority products** from a pipeline of ~10, with quarterly to biannual rebalancing based on **profitability and demand signals**. * **Dynamic Optimization:** Multipurpose plant leverages **adaptive production scheduling** to maximize margins amid shifting market conditions. ## D. Utilization Rates * **Utilization Strategy:** Expanded capacities being matched with **broader customer and geographic outreach** to ensure strong uptake and leadership retention. --- # 4. Export & Geography Mix ## A. Key Figures * **MMA Export Volumes:** **20,000–22,000 tons** (July, surge from deferred shipments and new orders) * **Exports (Quarterly):** **₹950 Cr** (impacted by falling raw material prices) * **US Revenue Exposure:** **15%–20%** direct export share, with potentially higher indirect exposure ## B. US Market Exposure * **Strategic Scaling Paused:** U.S. market expansion, particularly in MMA, has been scaled back due to **tariff uncertainty**, creating a temporary slowdown described as a "speed bump." * **Volume Pressures:** Lower DCB and NCB exports reflect reduced U.S. demand; near-term recovery not expected amid ongoing trade headwinds. * **Customer Reallocation Constraints:** PPS demand shift from U.S. auto customers is limited by **yearly contracts**, restricting intra-year flexibility but allowing adjustments in the next cycle. ## C. Europe & Diversification * **Tariff-Driven Recovery:** Phenylenediamine (PDA) chain is experiencing **significant volume recovery** due to favorable India-China tariff differentials. * **Geographic Rebalancing:** Company is actively expanding MMA presence in **Europe** to mitigate U.S.-related risks and diversify export destinations. ## D. Direct vs Indirect Sales * **Hidden US Exposure:** Indirect U.S. exposure may exceed direct levels via sales of intermediates to Indian agrochemical exporters serving the U.S. market. --- # 5. Cost & Margin Drivers ## A. Key Figures * **Raw Material Prices:** **$1,000/ton** aniline (from $1,600) · **₹58–59/kg** benzene (from ₹85–86) * **Cost Optimization Target:** **₹150–200 Cr** EBITDA improvement (3-year plan) * **EBITDA Deferment:** **₹15–20 Cr** due to logistical challenges in Q1 ## B. Raw Material Trends * **Pricing Volatility:** Key input costs declined 15–20% amid macro pressures, triggering inventory adjustments across the chain. * **Stabilization Signal:** Management sees raw material prices as having bottomed out, with minor upticks and stabilization over recent months. * **Supply Chain Risk:** Heavy reliance on imported aniline necessitates **5 to 2 months** of strategic inventory, increasing exposure to price swings. ## C. Cost Optimization * **Initiatives on Track:** Cost-saving programs are ahead of schedule, with yield improvements and a new back-pressure turbine enhancing efficiency. * **Near-Term Implementation:** **65–70%** of targeted EBITDA gains to be executed this year, though P&L benefits will be phased. * **Savings Timing:** Major renewable energy savings expected from **November–December (solar)** and **April–May next year (hybrid)**. ## D. Margin Recovery Path * **Bottoming Call:** Management believes overall margins have likely hit trough levels and will improve gradually over the medium term. * **Growth from New Capacity:** Margin-accretive contributions expected from Zone-IV and MPP expansions, targeting return to **20%+ EBITDA margins**. * **Offsetting Deterioration:** Cost actions have prevented sharper profit declines, supporting resilience despite pricing headwinds. ## E. Energy Cost Impact * **MMA Margin Pressure:** Current spread at **$13/barrel**, with energy costs cited as key constraint to achieving higher double-digit margins. * **Pricing Lag:** Despite volume gains and improving realizations in agrochemicals and dyes, broad pricing recovery delayed by structural supply chain dynamics. * **Downstream Delay:** Demand improvements at end markets benefit formulators first, with intermediate suppliers seeing delayed realization benefits. --- # 6. Risks & Trade Pressures ## A. Key Figures * **US Tariff Exposure:** **15–20%** of revenues at risk · **70–75%** of product basket faces Chinese competition * **Tariff Rates:** **25%** on MMA and select Indian imports · **Differential treatment** vs. Europe for DCB ## B. US Tariff Exposure * **Elevated Trade Risk:** Global trade instability from new **25% US tariff** and penalty framework creates pricing and profitability pressure; impact assessment remains preliminary due to recent regulatory changes. * **Targeted Product Impact:** MMA faces **affordability risks** in the US market under 25% tariff, with mitigation plans expected to be clarified in **two to three weeks**. * **Mitigation in Place:** No immediate impact observed for key agrochemical intermediates (DMS, ONA) as they are listed in the **'Annexure to Exemption List'**; company actively monitoring and preparing countermeasures. * **Competitive Disadvantage:** DCB faces **less favorable US tariff access vs. European producers**, increasing competitive pressure, though cost leadership supports market share retention. ## C. Chinese Competition * **Persistent but Stabilizing Pressure:** **70–75%** of portfolio competes with China; no material increase in competitive intensity, with core pricing believed to have hit a **structural floor**. * **Strategic Differentiation:** Company countering pricing pressure by shifting toward **unique chemistries** and portfolio optimization to reduce exposure. * **Early Signs of Relief:** Isolated improvements in realization and margins suggest **potential easing** of Chinese export aggression, though not yet a broad trend. * **Structural Overcapacity:** Significant excess capacity in China for **DCB and NCB** continues to weigh on global markets, limiting near-term pricing power. ## D. Geopolitical Disruptions * **Operational Interruptions:** **India-Pakistan tensions** caused blackouts and temporary shutdowns at **Kutch facility** and **Kandla Port**, reducing export volumes and capacity utilization. * **Global Logistics Shock:** **Israel-Iran conflict** disrupted regional shipping in May/June 2025, leading to rerouted and delayed shipments affecting Q1 export performance. * **Resilience Amid Volatility:** Despite **repeated supply chain shocks** over the past 5–6 months, company maintained agility through operational discipline, with domestic operations proving more stable. --- # 7. Guidance & Outlook ## A. Key Figures * **EBITDA Guidance:** **₹1,800 Cr** three-year target (achievable) * **Capex:** **₹280 Cr** (Q1 FY26) · **<₹1,000 Cr** expected for FY26 * **Prior Capex:** **₹1,300–1,400 Cr** in FY25, with significant decline expected next year ## B. EBITDA Target * **Long-Term Confidence:** Management reaffirms **₹1,800 Cr EBITDA target** over three years, citing clear growth levers including cost optimization and operating leverage. * **No Annual Guidance:** Company has discontinued annual EBITDA guidance due to geopolitical and trade policy uncertainties, despite maintaining long-term confidence. * **Value Realization Timeline:** Full financial potential of Zone-IV investment expected within **1.5 years**, with initial contributions from MPP and calcium chloride units starting next calendar year. ## C. Capex Plan * **Capex Discipline:** Marked shift toward stricter capital allocation, resulting in sustained reduction from prior-year levels and a significant drop expected in FY27. * **Committed Spend:** Current outlays primarily cover **completed or near-final projects** (e.g., multipurpose plant, Zone-IV) initiated 2–2.5 years ago under prior strategy. * **Future Investment Bar:** New expansions require **strong customer backing and ROI justification**; recent MMA ramp-up executed with limited capital to enhance returns. ## D. Volume Recovery * **H2 Volume Rebound Expected:** DCB and PDCB volumes anticipated to recover in second half, supported by annual contracts and customer production restarts post-inventory correction. * **Market Diversification:** Company actively pursuing new markets to offset near-term demand volatility in MMA segment. * **Tariff Overhang:** **25% tariff risk** on PDCB and broader trade barriers remain key concerns, though clients remain confident in H2 recovery as of 48 hours pre-call. ## E. H2 Improvement * **Q1 Weakness Transient:** Soft start attributed to temporary disruptions—including geopolitical-related plant issues and expansion shutdowns—with strong recovery expected in coming quarters. * **Profitability Trajectory:** Absolute profitability expected to grow in line with volumes going forward, signaling margin stabilization and improved operating leverage. * **Realization Recovery Lag:** Sustainable improvement in pricing and capacity absorption expected over a multi-quarter horizon, likely extending into **FY27**.